NCT06694077
Suprazygomatic Maxillary Nerve Block for Management of Postoperative Pain in Adenotonsillectomy Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
the total amount of analgesic requirements during first the 24hr after two different blocks.
Timeframe: Postoperative 24 hours
Secondary (1)
Postoperative pain score, Faces, Legs, Activity, Cry, Consolability (FLACC)
Arms and interventions
Bupivacaine with DexamethasoneExperimental
bilateral suprazygomatic maxillary nerve block will be performed with 1 mL of 0.5% bupivacaine was added to 0.1 mg.kg-1 dexamethasone and diluted to 2 mL with 0.9% saline.
Bupivacaine onlyExperimental
bilateral suprazygomatic maxillary nerve block will be performed with 1 mL of 0.5% bupivacaine alone and diluted to 2 mL with 0.9% saline
Drugs: Bupivacaine with Dexamethasone, Bupivacaine only